Literature DB >> 1733083

Withdrawal of steroids after renal transplantation--clinical predictors of outcome.

D E Hricik1, C C Whalen, J Lautman, M R Bartucci, E J Moir, J T Mayes, J A Schulak.   

Abstract

Withdrawal of steroid therapy in renal transplant recipients is associated with a risk of acute allograft rejection. To define clinical risk factors for rejection associated with steroid withdrawal, we analyzed the clinical characteristics of 107 patients with drawn from steroid therapy at various times after transplantation. Both univariate and multivariate analyses suggested that the timing of steroid withdrawal is an important predictor of steroid withdrawal failure. Withdrawal of steroids was successful in only 13 of 32 patients (41%) in whom prednisone was discontinued shortly after transplantation. In contrast, steroid withdrawal has been successful in 59 of 75 patients (79%) in whom prednisone was discontinued at least 6 months after transplantation. Black race and donor-recipient racial mismatch also were significant predictors of rejection associated with steroid withdrawal. In patients undergoing steroid withdrawal at least 6 months posttransplant, serum creatinine concentration also correlated independently with the risk of rejection. Neither age, sex, HLA match, pretransplant PRA, source of the allograft (cadaver vs. living relative), acute tubular necrosis, nor the presence of diabetes was predictive of the outcome of steroid withdrawal.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733083     DOI: 10.1097/00007890-199201000-00007

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  15 in total

Review 1.  Corticosteroid-sparing strategies in renal transplantation: are we still balancing rejection risk with improved tolerability?

Authors:  Oriol Bestard; Josep M Cruzado; Josep M Grinyó
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression.

Authors:  M L Jordan; P Chakrabarti; P Luke; R Shapiro; C A Vivas; V P Scantlebury; J J Fung; T E Starzl; R J Corry
Journal:  Transplantation       Date:  2000-01-27       Impact factor: 4.939

3.  Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression.

Authors:  P Chakrabarti; H Y Wong; V P Scantlebury; M L Jordan; C Vivas; D Ellis; S Lombardozzi-Lane; T R Hakala; J J Fung; R L Simmons; T E Starzl; R Shapiro
Journal:  Transplantation       Date:  2000-09-15       Impact factor: 4.939

Review 4.  Corticosteroid avoidance in pediatric renal transplantation: can it be achieved?

Authors:  Jayakumar R Vidhun; Minnie M Sarwal
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

5.  Effect of long-term steroid withdrawal in renal transplant recipients: a retrospective cohort study.

Authors:  Miguel Gonzalez-Molina; Miguel Angel Gentil; Dolores Burgos; Mercedes Cabello; Carmen Cobelo; Jesús Bustamante; Pedro Errasti; Antonio Franco; Domingo Hernández
Journal:  NDT Plus       Date:  2010-06

Review 6.  Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy?

Authors:  Fu L Luan; Diane E Steffick; Akinlolu O Ojo
Journal:  Kidney Int       Date:  2009-07-22       Impact factor: 10.612

Review 7.  Prevention and management of the adverse effects associated with immunosuppressive therapy.

Authors:  S J Rossi; T J Schroeder; S Hariharan; M R First
Journal:  Drug Saf       Date:  1993-08       Impact factor: 5.606

Review 8.  Calcineurin inhibitors in renal transplantation: what is the best option?

Authors:  Kazunari Tanabe
Journal:  Drugs       Date:  2003       Impact factor: 9.546

9.  Successful steroid withdrawal half a year after kidney transplantation.

Authors:  T Yagisawa; T Nakada; Y Hiromasa; H Kaneko; M Tomaru; Y Suzuki; Y Iijima
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

10.  FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression.

Authors:  M L Jordan; R Shapiro; C A Vivas; V P Scantlebury; P Rhandhawa; G Carrieri; J McCauley; A J Demetris; A Tzakis; J J Fung
Journal:  Transplantation       Date:  1994-03-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.